|

Tipifarnib Clinical Trials

1 actively recruiting trial across 1 location

Also known as: R115777

Pipeline

Phase 2: 1

Top Sponsors

  • Giselle Sholler1

Indications

  • Neuroblastoma1
  • Cancer1

Little Rock, Arkansas1 trial

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

Arkansas Children's Hospital

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.